Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research 2022-01-25 17:00
2022 Japan Prize Laureates Announced 2022-01-25 14:00
Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform 2022-01-25 13:23
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly 2022-01-24 23:35
Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation (ADDF) 2022-01-24 22:15
MGI's New MGISP-Smart 8 Automated Sample Preparation System Makes International Debut at MEDLAB Middle East 2022-01-24 19:30
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy 2022-01-24 15:22
Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers 2022-01-24 13:10
New York Medical Group Publishes Research on Tech Neck 2022-01-24 12:39
Infinitus releases 2021 Corporate Social Responsibility Report 2022-01-24 09:00
Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2022-01-23 18:35
Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022 2022-01-22 08:00
Swiss Pharma Company - IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat) 2022-01-22 04:24
Ashraya Foundation Signs 60 Crore INR Agreement with Edufront Technologies 2022-01-21 18:30
Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd. 2022-01-21 11:12
ESTA Lunar New Year with UltraBactech, proven to target and kill 99.999% of the SARS-CoV-2 virus, presents the new Spring collection design & gift sets 2022-01-21 10:30
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment 2022-01-21 05:30
Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022 2022-01-20 23:05
Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing 2022-01-20 21:15
Victor Papamoniodis Joins Medison Pharma as VP International Markets 2022-01-20 20:35
1 239 240 241 242 243 741